BEGIN:VCALENDAR
PRODID:-//github.com/rianjs/ical.net//NONSGML ical.net 4.0//EN
VERSION:2.0
BEGIN:VEVENT
DESCRIPTION:Together we will increase the length and quality of patient su
 rvival from diagnosis.\n\nThe 3rd Glioblastoma Drug Development Summit is
  the only industry led forum for large pharma\, biotech and academic KOLs
  to unite under the common goal of accelerating the practical translation
  and clinical development of meaningful therapies for the treatment of gl
 ioblastoma.\n\nThrough investigating the clinical implementation of diver
 se mechanisms of action\, including\, DNA damage repair\, immunotherapy\,
  oncolytic viruses\, cholesterol metabolism\, PARP inhibitors and more\, 
 we strive to address the urgent need for novel and much improved treatmen
 ts for this devastating disease.\n\nTackling specific drug development ch
 allenges such as a better understanding of preclinical efficacy and toler
 ability data to confidently translate into the clinic\, improving drug de
 livery across the blood-brain barrier and optimizing clinical trial desig
 n to define more measurable outcomes\, this meeting is an absolute must a
 ttend for all neuro-oncologists and oncology professionals determined to 
 translate their drug candidates into human clinical trials.\n\nWith a hug
 e unmet medical need for effective treatments and too many clinical failu
 res to overcome\, there has never been a more important time to attend th
 e 3rd Glioblastoma Drug Development Summit and join your dedicated and de
 termined community to defeat GBM and radically change patients’ lives.\n\
 nJoin us as we unite drug developers and academics to tackle unique drug 
 development challenges creating obstacles for effective treatments for GB
 M patients\n
DTEND:20220120T174000
DTSTAMP:20260512T230908Z
DTSTART:20220118T080000
LOCATION:Wyndham Boston Beacon Hill\, 5 Blossom Street\, Boston\, Massachu
 setts\, 02114\,
SEQUENCE:0
SUMMARY:Together we will increase the length and quality of patient surviv
 al from diagnosis.\nThe 3rd Glioblastoma Drug Development Summit is the o
 nly indu...
UID:0c015274-c670-4ff9-afa8-85e48ec09ae4
END:VEVENT
END:VCALENDAR
